featured
Trifluridine/Tipiracil Plus Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer Ineligible for Intensive Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trifluridine/Tipiracil Plus Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer Ineligible for Intensive Therapy: The Randomized TASCO1 Study
Ann. Oncol 2020 Jun 01;[EPub Ahead of Print], E Van Cutsem, I Danielewicz, MP Saunders, P Pfeiffer, G Argilés, C Borg, R Glynne-Jones, CJA Punt, AJ Van de Wouw, M Fedyanin, D Stroyakovskiy, H Kroening, P Garcia-Alfonso, H Wasan, A Falcone, A Kanehisa, A Egorov, P Aubel, N Amellal, V MoiseenkoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.